NCT07155655 is a NA clinical trial of Motor Imagery (MI) in Healthy Volunteers, sponsored by Mateo Riera Marco.

Who is sponsoring NCT07155655?

NCT07155655 is sponsored by Mateo Riera Marco.

What condition does NCT07155655 study?

NCT07155655 studies Healthy Volunteers, Muscle Strength.

Is NCT07155655 still recruiting?

NCT07155655 is currently completed. Last updated 4 September 2025.

Last reviewed 2025-09-04 · How we verify

NCT07155655

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Motivation and Mental Practice on Lumbo-Pelvic Strength in Healthy Adults

Completed NA Last updated 4 September 2025

What this trial tests

NA trial testing Motor Imagery (MI) in Healthy Volunteers in 40 participants. Completed in 3 June 2023.

Timeline

18 September 2022

Primary endpoint
25 May 2023

3 June 2023

Quick facts

Lead sponsor	Mateo Riera Marco
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	18 September 2022
Primary completion	25 May 2023
Estimated completion	3 June 2023
Sites	1 location across Spain

Drugs / interventions tested

Motor Imagery (MI)
Action Observation (AO)
Motor Imagery with Motivation (MIm)
Action Observation with Motivation (AOm)

Conditions studied

Healthy Volunteers — all drugs for Healthy Volunteers →
Muscle Strength — all drugs for Muscle Strength →

Sponsor

Mateo Riera Marco

Who can join

Adults 18 to 65, any sex, with Healthy Volunteers or Muscle Strength. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot randomized controlled trial investigated the influence of motivation combined with motor imagery (MI) or action observation (AO) on lumbo-pelvic strength in asymptomatic adults. The purpose was to explore whether adding a motivational protocol to mental practice strategies could enhance strength outcomes. Forty healthy participants were randomly assigned to one of four groups: motor imagery (MI), action observation (AO), motor imagery with motivation (MIm), or action observation with motivation (AOm). Lumbo-pelvic strength was measured using a dynamometer, while imagery ability was evaluated with the revised Movement Imagery Questionnaire (MIQ-R). Assessments were performed at baseline and post-intervention, with strength additionally measured pre-, intra-, and post-intervention. The trial was conducted between September 2022 and June 2023 at Centro de Estudios Universitarios La Salle, Madrid, Spain, during the investigator's student affiliation. This study is being registered retrospectively to meet ethical and publication requirements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Motor Imagery (MI)

Trials testing the same drug.

NCT06230718 — EMG Analysis in ABI: Motor Imagery and Action · NA · recruiting
NCT06414213 — Improving Locomotor Learning With Brain Stimulation · NA · completed

Other recruiting trials for Healthy Volunteers

Currently open trials in the same condition.

NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease · Phase 1 · recruiting
NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07155655 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mateo Riera Marco
Last refreshed: 4 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07155655.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing